CVS Health Statistics
Total Valuation
CVS Health has a market cap or net worth of $55.82 billion. The enterprise value is $128.85 billion.
| Market Cap | 55.82B |
| Enterprise Value | 128.85B |
Important Dates
The next estimated earnings date is Wednesday, February 5, 2025, before market open.
| Earnings Date | Feb 5, 2025 |
| Ex-Dividend Date | Oct 21, 2024 |
Share Statistics
CVS Health has 1.26 billion shares outstanding. The number of shares has decreased by -2.08% in one year.
| Current Share Class | 1.26B |
| Shares Outstanding | 1.26B |
| Shares Change (YoY) | -2.08% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.11% |
| Owned by Institutions (%) | 82.34% |
| Float | 1.26B |
Valuation Ratios
The trailing PE ratio is 11.22 and the forward PE ratio is 7.63.
| PE Ratio | 11.22 |
| Forward PE | 7.63 |
| PS Ratio | 0.15 |
| Forward PS | 0.14 |
| PB Ratio | 0.74 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 33.09 |
| P/OCF Ratio | 12.11 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.13, with an EV/FCF ratio of 76.38.
| EV / Earnings | 25.69 |
| EV / Sales | 0.35 |
| EV / EBITDA | 9.13 |
| EV / EBIT | 13.52 |
| EV / FCF | 76.38 |
Financial Position
The company has a current ratio of 0.80, with a Debt / Equity ratio of 1.10.
| Current Ratio | 0.80 |
| Quick Ratio | 0.54 |
| Debt / Equity | 1.10 |
| Debt / EBITDA | 4.80 |
| Debt / FCF | 49.02 |
| Interest Coverage | 3.30 |
Financial Efficiency
Return on equity (ROE) is 6.70% and return on invested capital (ROIC) is 3.81%.
| Return on Equity (ROE) | 6.70% |
| Return on Assets (ROA) | 2.37% |
| Return on Capital (ROIC) | 3.81% |
| Revenue Per Employee | $1.22M |
| Profits Per Employee | $16,720 |
| Employee Count | 300,000 |
| Asset Turnover | 1.46 |
| Inventory Turnover | 17.78 |
Taxes
In the past 12 months, CVS Health has paid $1.72 billion in taxes.
| Income Tax | 1.72B |
| Effective Tax Rate | 25.52% |
Stock Price Statistics
The stock price has decreased by -41.83% in the last 52 weeks. The beta is 0.54, so CVS Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.54 |
| 52-Week Price Change | -41.83% |
| 50-Day Moving Average | 56.17 |
| 200-Day Moving Average | 60.81 |
| Relative Strength Index (RSI) | 27.05 |
| Average Volume (20 Days) | 14,951,517 |
Short Selling Information
The latest short interest is 17.77 million, so 1.41% of the outstanding shares have been sold short.
| Short Interest | 17.77M |
| Short Previous Month | 21.85M |
| Short % of Shares Out | 1.41% |
| Short % of Float | 1.42% |
| Short Ratio (days to cover) | 1.45 |
Income Statement
In the last 12 months, CVS Health had revenue of $367.25 billion and earned $5.02 billion in profits. Earnings per share was $3.95.
| Revenue | 367.25B |
| Gross Profit | 50.71B |
| Operating Income | 9.53B |
| Pretax Income | 9.63B |
| Net Income | 5.02B |
| EBITDA | 14.12B |
| EBIT | 9.53B |
| Earnings Per Share (EPS) | $3.95 |
Balance Sheet
The company has $9.68 billion in cash and $82.70 billion in debt, giving a net cash position of -$73.02 billion or -$58.03 per share.
| Cash & Cash Equivalents | 9.68B |
| Total Debt | 82.70B |
| Net Cash | -73.02B |
| Net Cash Per Share | -$58.03 |
| Equity (Book Value) | 75.11B |
| Book Value Per Share | 59.57 |
| Working Capital | -17.28B |
Cash Flow
In the last 12 months, operating cash flow was $4.61 billion and capital expenditures -$2.92 billion, giving a free cash flow of $1.69 billion.
| Operating Cash Flow | 4.61B |
| Capital Expenditures | -2.92B |
| Free Cash Flow | 1.69B |
| FCF Per Share | $1.34 |
Margins
Gross margin is 13.81%, with operating and profit margins of 2.60% and 1.37%.
| Gross Margin | 13.81% |
| Operating Margin | 2.60% |
| Pretax Margin | 1.83% |
| Profit Margin | 1.37% |
| EBITDA Margin | 3.84% |
| EBIT Margin | 2.60% |
| FCF Margin | 0.46% |
Dividends & Yields
This stock pays an annual dividend of $2.66, which amounts to a dividend yield of 6.00%.
| Dividend Per Share | $2.66 |
| Dividend Yield | 6.00% |
| Dividend Growth (YoY) | 9.92% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 67.26% |
| Buyback Yield | 2.08% |
| Shareholder Yield | 8.08% |
| Earnings Yield | 8.99% |
| FCF Yield | 3.02% |
Analyst Forecast
The average price target for CVS Health is $71.12, which is 60.33% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $71.12 |
| Price Target Difference | 60.33% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 17 |
| Revenue Growth Forecast (5Y) | 5.01% |
| EPS Growth Forecast (5Y) | 8.64% |
Stock Splits
The last stock split was on June 7, 2005. It was a forward split with a ratio of 2:1.
| Last Split Date | Jun 7, 2005 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
CVS Health has an Altman Z-Score of 2.13 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.13 |
| Piotroski F-Score | 4 |